254 related articles for article (PubMed ID: 27273962)
21. New Hybrid Scaffolds Based on Carbazole-Chalcones as Potent Anticancer Agents.
Rashid F; Zaib S; Ibrar A; Ejaz SA; Saeed A; Iqbal J; Khan I
Anticancer Agents Med Chem; 2021; 21(9):1082-1091. PubMed ID: 32698741
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, characterization and anticancer effect of the ruthenium (II) polypyridyl complexes on HepG2 cells.
Wan D; Lai SH; Yang HH; Tang B; Zhang C; Yin H; Zeng CC; Liu YJ
J Photochem Photobiol B; 2016 Dec; 165():246-255. PubMed ID: 27816647
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
[TBL] [Abstract][Full Text] [Related]
24. Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation.
Griffith D; Cecco S; Zangrando E; Bergamo A; Sava G; Marmion CJ
J Biol Inorg Chem; 2008 May; 13(4):511-20. PubMed ID: 18183430
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of topoisomerase II catalytic activity by two ruthenium compounds: a ligand-dependent mode of action.
Gopal YN; Jayaraju D; Kondapi AK
Biochemistry; 1999 Apr; 38(14):4382-8. PubMed ID: 10194357
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of imidazo[2,1-b]thiazole-chalcone conjugates: microtubule-destabilizing agents.
Kamal A; Balakrishna M; Nayak VL; Shaik TB; Faazil S; Nimbarte VD
ChemMedChem; 2014 Dec; 9(12):2766-80. PubMed ID: 25313981
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
[TBL] [Abstract][Full Text] [Related]
28. Exploring the cytotoxicity of dinuclear Ru(II)
Abirami A; Devan U; Ramesh R; Antony Joseph Velanganni A; Małecki JG
Dalton Trans; 2024 Mar; 53(11):5167-5179. PubMed ID: 38380977
[TBL] [Abstract][Full Text] [Related]
29. Protein-binding, cytotoxicity in vitro and cell cycle arrest of ruthenium(II) polypyridyl complexes.
Liu SH; Zhu JW; Xu HH; Wang Y; Liu YM; Liang JB; Zhang GQ; Cao DH; Lin YY; Wu Y; Guo QF
Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():77-82. PubMed ID: 26956530
[TBL] [Abstract][Full Text] [Related]
30. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F
Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730
[TBL] [Abstract][Full Text] [Related]
31. Anticancer activity of two novel ruthenium compounds in gastric cancer cells.
Ramírez-Rivera S; Pizarro S; Gallardo M; Gajardo F; Delgadillo A; De La Fuente-Ortega E; MacDonnell FM; Bernal G
Life Sci; 2018 Nov; 213():57-65. PubMed ID: 30326218
[TBL] [Abstract][Full Text] [Related]
32. β-Ionone derived chalcones as potent antiproliferative agents.
Sharma V; Chaudhary A; Arora S; Saxena AK; Ishar MP
Eur J Med Chem; 2013 Nov; 69():310-5. PubMed ID: 24056146
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
[TBL] [Abstract][Full Text] [Related]
34. Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines.
Maioral MF; Gaspar PC; Rosa Souza GR; Mascarello A; Chiaradia LD; Licínio MA; Moraes AC; Yunes RA; Nunes RJ; Santos-Silva MC
Biochimie; 2013 Apr; 95(4):866-74. PubMed ID: 23257665
[TBL] [Abstract][Full Text] [Related]
35. Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors.
Bratsos I; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
J Inorg Biochem; 2008 Apr; 102(4):606-17. PubMed ID: 18063052
[TBL] [Abstract][Full Text] [Related]
36. Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies.
Yan C; Zhang J; Liang T; Li Q
Biomed Pharmacother; 2015 Apr; 71():119-27. PubMed ID: 25960226
[TBL] [Abstract][Full Text] [Related]
37. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway.
Takac P; Kello M; Pilatova MB; Kudlickova Z; Vilkova M; Slepcikova P; Petik P; Mojzis J
Chem Biol Interact; 2018 Aug; 292():37-49. PubMed ID: 29981726
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
[TBL] [Abstract][Full Text] [Related]
39. Osthole induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Chao X; Zhou X; Zheng G; Dong C; Zhang W; Song X; Jin T
Pharm Biol; 2014 May; 52(5):544-50. PubMed ID: 24236568
[TBL] [Abstract][Full Text] [Related]
40. 2-(3,5-Dibromo-4-hydroxyphenyl)imidazo[4,5-f][1,10]phenanthrolinoruthenium(II) complexes: synthesis, characterization, cytotoxicity, apoptosis, DNA-binding and antioxidant activity.
Liu YJ; Liang ZH; Li ZZ; Zeng CH; Yao JH; Huang HL; Wu FH
Biometals; 2010 Aug; 23(4):739-52. PubMed ID: 20422275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
